BIOMAT Database Logo BIOMAT Database Logo

Lactic acidosis associated with nucleoside reverse transcriptase inhibitors. 2000

P M Caffrey
Nicholas A. Rango Health Care Facility, New York, NY, USA.

Limitations on antiretroviral therapies as a result of resistance and adverse events have been described in the literature. Lactic acidosis has been reported in patients on nucleoside reverse transcriptase inhibitors on rare occasions. Successful assessment and treatment of lactic acidosis is dependent on the nurse's role in the recognition of this condition. This article provides an overview of the clinical presentation, diagnosis, treatment strategies and nursing management of lactic acidosis in patients with HIV/AIDS.

UI MeSH Term Description Entries
D009730 Nursing Assessment Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning. Nursing Protocols,Assessment, Nursing,Protocols, Nursing,Assessments, Nursing,Nursing Assessments,Nursing Protocol,Protocol, Nursing
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000140 Acidosis, Lactic Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as DIABETES MELLITUS; LEUKEMIA; or LIVER FAILURE. Lactic Acidosis
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

P M Caffrey
Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis.
December 2000, AIDS (London, England),
P M Caffrey
[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors].
July 2005, Medicina clinica,
P M Caffrey
Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
June 2003, Critical care (London, England),
P M Caffrey
Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors.
January 2001, AIDS (London, England),
P M Caffrey
Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors.
December 2002, The New England journal of medicine,
P M Caffrey
Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
May 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P M Caffrey
[Non-nucleoside reverse transcriptase inhibitors].
June 2000, Annales de medecine interne,
P M Caffrey
HIV nucleoside reverse transcriptase inhibitors.
October 2022, European journal of medicinal chemistry,
P M Caffrey
Non-nucleoside reverse transcriptase inhibitors.
June 1996, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation,
P M Caffrey
Hepatotoxicity of nucleoside reverse transcriptase inhibitors.
May 2003, Seminars in liver disease,
Copied contents to your clipboard!